DK1303267T3 - System til dermal tilförsel af aminolevulinsyre - Google Patents

System til dermal tilförsel af aminolevulinsyre

Info

Publication number
DK1303267T3
DK1303267T3 DK01960499T DK01960499T DK1303267T3 DK 1303267 T3 DK1303267 T3 DK 1303267T3 DK 01960499 T DK01960499 T DK 01960499T DK 01960499 T DK01960499 T DK 01960499T DK 1303267 T3 DK1303267 T3 DK 1303267T3
Authority
DK
Denmark
Prior art keywords
aminolevulinic acid
dermal administration
dermal
aminolaevulinic
acid
Prior art date
Application number
DK01960499T
Other languages
Danish (da)
English (en)
Inventor
Geoffrey Lee
Rolf-Markus Szeimies
Original Assignee
Photonamic Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonamic Gmbh & Co Kg filed Critical Photonamic Gmbh & Co Kg
Application granted granted Critical
Publication of DK1303267T3 publication Critical patent/DK1303267T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01960499T 2000-07-17 2001-07-13 System til dermal tilförsel af aminolevulinsyre DK1303267T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10034673A DE10034673C1 (de) 2000-07-17 2000-07-17 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung

Publications (1)

Publication Number Publication Date
DK1303267T3 true DK1303267T3 (da) 2004-06-14

Family

ID=7649181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01960499T DK1303267T3 (da) 2000-07-17 2001-07-13 System til dermal tilförsel af aminolevulinsyre

Country Status (19)

Country Link
US (1) US7951395B2 (hu)
EP (1) EP1303267B1 (hu)
JP (1) JP4469131B2 (hu)
AT (1) ATE263557T1 (hu)
AU (2) AU8198001A (hu)
CA (1) CA2416147C (hu)
CZ (1) CZ299086B6 (hu)
DE (2) DE10034673C1 (hu)
DK (1) DK1303267T3 (hu)
ES (1) ES2215924T3 (hu)
HU (1) HU230272B1 (hu)
NO (1) NO330303B1 (hu)
NZ (1) NZ523798A (hu)
PL (1) PL221283B1 (hu)
PT (1) PT1303267E (hu)
RU (1) RU2262930C2 (hu)
TR (1) TR200400865T4 (hu)
WO (1) WO2002005809A1 (hu)
ZA (1) ZA200210267B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
WO2006041908A2 (en) * 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
DE102011111865A1 (de) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
EP4183328A1 (en) 2017-04-04 2023-05-24 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
US11131796B2 (en) 2018-09-10 2021-09-28 Texas Instruments Incorporated Optical display with spatial light modulator

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3827561C1 (hu) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE69330277T2 (de) 1992-09-21 2002-04-18 Quadra Logic Tech Inc Transkutane in-vivo aktivierung von photoempfindlichen mitteln im blut
DE4320871C2 (de) 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
EP0704209A1 (en) * 1994-09-20 1996-04-03 JOHNSON & JOHNSON MEDICAL, INC. Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
JPH11514986A (ja) 1995-09-21 1999-12-21 ノバルティス アクチエンゲゼルシャフト 光力学的療法におけるナノ粒子
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
OA12846A (en) 2001-11-08 2006-09-15 Elan Pharm Inc N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives.
DE10202487A1 (de) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate

Also Published As

Publication number Publication date
US20050013852A1 (en) 2005-01-20
JP4469131B2 (ja) 2010-05-26
AU2001281980B2 (en) 2006-04-06
CZ2003118A3 (cs) 2003-05-14
CA2416147C (en) 2008-11-18
DE10034673C1 (de) 2002-04-25
CA2416147A1 (en) 2002-01-24
NZ523798A (en) 2005-04-29
EP1303267A1 (de) 2003-04-23
ATE263557T1 (de) 2004-04-15
ZA200210267B (en) 2003-06-12
EP1303267B1 (de) 2004-04-07
PL221283B1 (pl) 2016-03-31
NO330303B1 (no) 2011-03-28
AU8198001A (en) 2002-01-30
JP2004503591A (ja) 2004-02-05
ES2215924T3 (es) 2004-10-16
RU2262930C2 (ru) 2005-10-27
CZ299086B6 (cs) 2008-04-23
HUP0301089A2 (hu) 2003-09-29
DE50101929D1 (de) 2004-05-13
HU230272B1 (hu) 2015-11-30
PT1303267E (pt) 2004-07-30
HUP0301089A3 (en) 2006-07-28
NO20030182D0 (no) 2003-01-14
US7951395B2 (en) 2011-05-31
WO2002005809A1 (de) 2002-01-24
NO20030182L (no) 2003-01-14
TR200400865T4 (tr) 2004-06-21
PL365380A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
CY1106577T1 (el) Δερματικο συστημα χορηγησης για παραγωγα αμινολεβουλινικου οξεος
CR6895A (es) Nuevos compuestos heterociclicos su preparacion y su utilizacion como medicamentos en especial como antibacterianos
UY26841A1 (es) Sales estables de ácido o-acetilsalicílico con aminoácidos básicos
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
DK1303267T3 (da) System til dermal tilförsel af aminolevulinsyre
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
BR0009762A (pt) Catalisador para produção de ácido acético ou ácido acético e acetato de etila, processo para sua produção e processo para produção de ácido acético ou ácido acético e acetato de etila usando-o
ES2184408T3 (es) Sistema transdermico que contiene un antioxidante.
AR024944A1 (es) Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
NO20044041L (no) Okso-azabisykliske forbindelser
BR0013515A (pt) Inibidores de sintase de ácido graxo
RS63804A (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
DK0938584T3 (da) Fremgangsmåde til fremstilling af (S)-eller (R)-3,3,3-trifluor-2-hydroxy-2-methylpropionsyre
ATE286395T1 (de) Antithrombotische mittel
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
DK1017666T3 (da) Fremgangsmåde til at forøge den optiske renhed af 2R-[1-hydroxy-1-trifluormethyl-3-cyclopropylpropyn-2-yl]-4-chloranilin
BR0207953A (pt) Derivados de caloporosida, processos para a sua preparação e sua aplicação
BR9908511A (pt) Processo para a preparação de um composto, e, composto
ES2042409B1 (es) Procedimiento para la preparacion de d-aminoacidos o derivados de d-aminoacidos.
BR0112849A (pt) Processo para a preparação de um composto quiral, e, composto quiral
ATE323105T1 (de) Von lipocortin-1 abgeleitete entzündungshemmende wirkstoffe
ATE259802T1 (de) Verbindungen mit antithrombotischer wirkung
DE69824410D1 (en) Antithrombosemittel